SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
03-Sep-24 5:38 PM View: | Quince Therapeutics, Inc. (QNCX) | 30-Aug-24 | Purchase | 77,000 | $0.70 | $53,900.00 | 10% 766.94K to 843.94K | |
03-Sep-24 5:38 PM View: | Quince Therapeutics, Inc. (QNCX) | 29-Aug-24 | Private Purchase | 77,500 | $0.69 | $53,475.00 | 11% 689.44K to 766.94K | |
17-Jan-24 4:48 PM View: | Quince Therapeutics, Inc. (QNCX) | 16-Jan-24 | Option Exercise | 240,530 | $0.79 | $190,791.00 | 54% 448.91K to 689.44K | |
11-Aug-23 4:15 PM View: | Quince Therapeutics, Inc. (QNCX) | 10-Aug-23 | Private Purchase | 88,000 | $1.26 | $110,880.00 | 24% 360.91K to 448.91K | |
09-Aug-23 6:23 PM View: | Quince Therapeutics, Inc. (QNCX) | 08-Aug-23 | Private Purchase | 80,000 | $1.24 | $99,200.00 | 28% 280.91K to 360.91K | |
23-May-22 8:29 PM View: | Quince Therapeutics, Inc. (QNCX) | 19-May-22 | Grant | 64,589 | -- | -- | 100% 0 to 64.59K |